• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Triptolide

Triptolide

Product ID T7035
Cas No. 38748-32-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $45.30 In stock
5 mg $147.20 In stock
25 mg $443.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Triptolide is a diterpenoid epoxide originally found in Tripterygium that exhibits anticancer chemotherapeutic, anti-angiogenic, antinociceptive, anti-inflammatory, anti-fibrotic, and immunosuppressive activities. Triptolide induces apoptosis and decreases β-catenin expression in breast cancer cells. In cellular and animal models of pancreatic cancer, triptolide inhibits cell proliferation and xenograft growth, downregulates expression of COX-2 and VEGF, and suppresses cell migration and tube formation. In animal models, chronic administration of triptolide decreases activation of glial cells and phosphorylation of MAPKs, suppressing neuropathic pain. Additionally, triptolide decreases expression of IL-17 and STAT3 and suppresses neutrophil migration, displaying hepatoprotective benefit in animal models of liver ischemia/reperfusion injury. Triptolide also prevents the development of cardiac fibrosis and improves cardiac function in animal models of chronic heart failure.

Product Info

Cas No.

38748-32-2

Purity

≥98%

Formula

C20H24O6

Formula Wt.

360.40

IUPAC Name

(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one

Synonym

PG490

Melting Point

227-228°C

Solubility

Soluble in DMSO.

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

T7035 MSDS PDF

Info Sheet

T7035 Info Sheet PDF

Brochures

WNT Booklet

References

Liu M, Chen J, Huang Y, et al. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway. Pharmazie. 2015 Apr;70(4):244-50.PMID: 26012254.

Shao H, Ma J, Guo T, et al. Triptolide induces apoptosis of breast cancer cells via a mechanism associated with the Wnt/β-catenin signaling pathway. Exp Ther Med. 2014 Aug;8(2):505-508. PMID: 25009609.

Ma JX, Sun YL, Wang YQ, et al. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res. 2013;20(8):359-68. PMID: 23924856.

Wang W, Mei XP, Chen L, et al. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response. Pain Physician. 2012 Nov-Dec;15(6):E995-1006. PMID: 23159984.

Wu C, Xia Y, Wang P, et al. Triptolide protects mice from ischemia/reperfusion injury by inhibition of IL-17 production. Int Immunopharmacol. 2011 Oct;11(10):1564-72. PMID: 21621648.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • V9202

    VX-702

    p38 MAPK inhibitor.

    ≥98%
  • H9718

    2-Hydroxyflutamide

    Non-steroid; AR antagonist.

    ≥98%
  • W9600

    WZ-4002

    EGFR (T790M) inhibitor.

    ≥98%
  • P200097

    PF-06821497

    EZH2 inhibitor

    ≥99%
  • A7461

    Asperosaponin VI

    Triterpene saponin found in Dipsacus asper.

    ≥98%
  • P6870

    Propofol

    GABA-A agonist, NMDA antagonist, voltage-gated ...

    ≥98%
  • M5752

    Monastrol

    Pyrimidine derivative; kinesin Eg5 inhibitor.

    ≥95%
  • T8269

    (S)-ar-Turmerone

    Sesquiterpene found in Curcuma.

    ≥97%
  • R5894

    Roxatidine Acetate Hydrochloride

    Histamine H2 antagonist.

    ≥98%
  • S8243

    Sulbactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • A9601

    AZD-5363

    AKT inhibitor, potential ROCK, p70S6K, PKA, MKK...

    ≥99%, ≥99%ee
  • I530280

    INH1

    Hec1/Nek2 mitotic pathway inhibitor

    ≥98%
  • M1774

    2-Mercaptoethanesulfonate Sodium

    Organosulfur, antioxidant.

    ≥98%
  • Q8134

    Quinapril Hydrochloride

    ACE inhibitor.

    ≥98%
  • C458567

    Clofazimine

    Antibacterial (Antimyobacterial) agent.

    ≥99%
  • C4659

    Clobetasol Propionate

    Corticosteroid; glucocorticoid agonist.

    ≥98%
  • B1746

    Belinostat

    HDAC inhibitor.

    ≥98%
  • A0248

    BAM-12P

    Peptide, cleavage product of proenkephalin; κO...

    ≥95%
  • D5868

    Doramapimod

    JNK, ALK, p38 MAPK inhibitor.

    ≥99%
  • E5569

    Enramycin B

    Polypeptide; peptidoglycan inhibitor.

    ≥83%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only